Altruism among participants in cancer clinical trials

Clinical Trials

Volumn 8, Issue 5, 2011, Pages 616-623

  Truong, Tony H ^a   Weeks, Jane C ^b   Cook, E Francis ^c   Joffe, Steven ^b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTRUISM; ARTICLE; BRAIN TUMOR; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; DECISION MAKING; DISEASE FREE SURVIVAL; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; MULTIVARIATE ANALYSIS; PARENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SOLID TUMOR;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; ALTRUISM; CLINICAL TRIALS AS TOPIC; CONFIDENCE INTERVALS; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NEOPLASMS; ODDS RATIO; PARENT-CHILD RELATIONS; PATIENT PARTICIPATION; PROGNOSIS; PSYCHOMETRICS; QUESTIONNAIRES; STATISTICS AS TOPIC;

EID: 80054811971     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774511414444     Document Type: Article

References (28)

1. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Cent Rep. 1987 ; 17: 20-4
2. Lidz CW, Appelbaum PS, Grisso T, Renaud M. Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med. 2004 ; 58: 1689-97 (Pubitemid 38281135)
3. Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: The patients' point of view. Control Clin Trials. 1985 ; 6: 156-67 (Pubitemid 15001285)
4. Catania C, De Pas T, Goldhirsch A, et al. Participation in clinical trials as viewed by the patient: Understanding cultural and emotional aspects which influence choice. Oncology. 2008 ; 74: 177-87
5. Langley JM, Halperin SA, Mills EL, Eastwood B. Parental willingness to enter a child in a controlled vaccine trial. Clin Invest Med. 1998 ; 21: 12-16 (Pubitemid 28127825)
6. Tait AR, Voepel-Lewis T, Malviya S. Participation of children in clinical research: Factors that influence a parent's decision to consent. Anesthesiology. 2003 ; 99: 819-25 (Pubitemid 37186070)
7. Verheggen FW, Nieman F, Jonkers R. Determinants of patient participation in clinical studies requiring informed consent: Why patients enter a clinical trial. Patient Educ Couns. 1998 ; 35: 111-25 (Pubitemid 28412668)
8. Daugherty CK, Banik DM, Janish L, Ratain MJ. Quantitative analysis of ethical issues in phase I trials: A survey interview of 144 advanced cancer patients. IRB. 2000 ; 22: 6-14
9. Kass N, Taylor H, Fogarty L, et al. Purpose and benefits of early phase cancer trials: What do oncologists say? What do patients hear?. J Empir Res Hum Res Ethics. 2008 ; 3: 57-68
10. Nurgat ZA, Craig W, Campbell NC, et al. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer. 2005 ; 92: 1001-5 (Pubitemid 40546660)
11. Tomamichel M, Jaime H, Degrate A, et al. Proposing phase I studies: Patients', relatives', nurses' and specialists' perceptions. Ann Oncol. 2000 ; 11: 289-94
12. Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995 ; 13: 1062-72
13. Edwards SJ, Lilford RJ, Braunholtz DA, et al. Ethical issues in the design and conduct of randomised controlled trials. Health Technol Assess. 1998 ; 2 (i-vi). 1-132
14. Edwards SJ, Lilford RJ, Hewison J. The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. BMJ. 1998 ; 317: 1209-12 (Pubitemid 28488512)
15. Advisory Committee on Human Radiation Experiments. The human radiation experiments: Final report. Oxford University Press, New York, NY. 1996; 469-469.
16. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000 ; 82: 1783-8 (Pubitemid 30307389)
17. Simon C, Eder M, Kodish E, Siminoff L. Altruistic discourse in the informed consent process for childhood cancer clinical trials. Am J Bioeth. 2006 ; 6: 40-7 (Pubitemid 44451634)
18. Meropol NJ, Weinfurt KP, Burnett CB, et al. Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. J Clin Oncol. 2003 ; 21: 2589-96 (Pubitemid 46606342)
19. Rodenhuis S, van den Heuvel WJ, Annyas AA, et al. Patient motivation and informed consent in a phase I study of an anticancer agent. Eur J Cancer Clin Oncol. 1984 ; 20: 457-62 (Pubitemid 14138849)
20. Cox K. Informed consent and decision-making: Patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Educ Couns. 2002 ; 46: 31-8 (Pubitemid 34136106)
21. Berg SL, Winick N, Ingle AM, et al. Reasons for participation in optional pharmacokinetic studies in children with cancer: A Children's Oncology Group phase 1 consortium study. Pediatr Blood Cancer. 2010 ; 55: 119-22
22. Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet. 2001 ; 358: 1772-7 (Pubitemid 33153003)
23. Roberts TG, Goulart BH, Squitieri L, et al. Trends inthe risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA. 2004 ; 292: 2130-40 (Pubitemid 39435104)
24. Horstmann E, McCabe MS, Grochow L, et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. NEngl J Med. 2005 ; 352: 895-904 (Pubitemid 40300298)
25. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Biomedical and Behavioral Research (Washington, DC: U.S. Government Printing Office, 1979).
26. Shah S, Weitman S, Langevin AM, et al. Phase I therapy trials in children with cancer. J Pediatr Hematol Oncol. 1998 ; 20: 431-8 (Pubitemid 29133197)
27. Joffe S. Altruistic discourse and therapeutic misconception in research informed consent. Am J Bioeth. 2006 ; 6: 53-4 (Pubitemid 44451639)
28. Wendler D, Jenkins T. Children's and their parents' views on facing research risks for the benefit of others. Arch Pediatr Adolesc Med. 2008 ; 162: 9-14